CYP2D6 genes and risk of liver cancer

This publication has 8 references indexed in Scilit:

• Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine.
  Proceedings of the National Academy of Sciences, 1993
• Relationship between the debrisoquine hydroxylase polymorphism and cancer susceptibility
  Carcinogenesis: Integrative Cancer Research, 1992
• Identification of a new variant CYP2D6 allele lacking the codon encoding Lys-281: possible association with the poor metabolizer phenotype
  Pharmacogenetics, 1991
• Debrisoquine/Sparteine Hydroxylation Genotype and Phenotype: Analysis of Common Mutations and Alleles ofCYP2D6in a European Population
  DNA and Cell Biology, 1991
• Relevance of metabolic polymorphisms to human carcinogenesis: evaluation of epidemiologic evidence
  Pharmacogenetics, 1991
• A tobacco smoke-derived nitrosamine, 4-(methytnitrosamino)-1-(3-pyridyl)-1-butanone, is activated by multiple human cytocbrome P450s including the polymorphic human cytochrome P4502D6
  Carcinogenesis: Integrative Cancer Research, 1991
• Genotyping of poor metabolisers of debrisoquine by allele-specific PCR amplification
  The Lancet, 1990
• Five of 12 forms of vaccinia virus-expressed human hepatic cytochrome P450 metabolically activate aflatoxin B1.
  Proceedings of the National Academy of Sciences, 1990